Tenax Therapeutics Inc
F:YBOC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Tenax Therapeutics Inc
F:YBOC
|
US |
|
E
|
Erste Group Bank AG
XHAM:EBO
|
AT |
|
Jungfraubahn Holding AG
SIX:JFN
|
CH |
|
Azimut Exploration Inc
OTC:AZMTF
|
CA |
|
C
|
Ctac NV
AEX:CTAC
|
NL |
|
Precision BioSciences Inc
F:PBS0
|
US |
|
M
|
MorphoSys AG
DUS:MOR
|
DE |
|
T
|
Takeda Pharmaceutical Co Ltd
XMUN:TKD
|
JP |
|
T
|
TransUnion
F:1TU
|
US |
|
S
|
Sixt SE
XMUN:SIX2
|
DE |
|
LG Display Co Ltd
KRX:034220
|
KR |
|
Petmed Express Inc
NASDAQ:PETS
|
US |
|
R
|
Re/Max Holdings Inc
XBER:2RM
|
US |
Wall St Price Targets
YBOC Price Targets Summary
Tenax Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
YBOC is 0.247 EUR with a low forecast of 0.176 EUR and a high forecast of 0.351 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is YBOC's stock price target?
Price Target
0.247
EUR
According to Wall Street analysts, the average 1-year price target for
YBOC is 0.247 EUR with a low forecast of 0.176 EUR and a high forecast of 0.351 EUR.